Frontiers | The Kappa Opioid Receptor: From Addiction to Depression, and Back
Signaling Properties of Structurally Diverse Kappa Opioid Receptor Ligands: Toward in Vitro Models of in Vivo Responses | ACS Chemical Neuroscience
Opioids to Treat Depression: The Jury Is Out
A systematic review on the kappa opioid receptor and its ligands: New directions for the treatment of pain, anxiety, depression, and drug abuse - ScienceDirect
Kappa Opioid Receptors Drive a Tonic Aversive Component of Chronic Pain | Journal of Neuroscience
The Role of Opioids and Their Receptors in Urological Malignancy: A Review | Journal of Urology
In major depression, increased kappa and mu opioid receptor levels are associated with immune activation | Acta Neuropsychiatrica | Cambridge Core
Structure-Based Discovery of New Antagonist and Biased Agonist Chemotypes for the Kappa Opioid Receptor | Journal of Medicinal Chemistry
Frontiers | Opioid Receptor-Mediated Regulation of Neurotransmission in the Brain
Biased agonists of the kappa opioid receptor suppress pain and itch without causing sedation or dysphoria | Science Signaling
Major Depressive Disorder and Kappa Opioid Receptor
Diverse Kappa Opioid Receptor Agonists: Relationships Between Signaling and Behavior
Role of kappa-opioid receptors in stress and anxiety-related behavior. - Abstract - Europe PMC
Kappa opioid receptor signaling in the brain: Circuitry and implications for treatment - ScienceDirect
Frontiers | The Kappa Opioid Receptor: From Addiction to Depression, and Back
Peripheral Kappa Opioid Receptor Signaling Takes on a Central Role - ScienceDirect
Dynorphin/kappa-opioid receptor control of dopamine dynamics: Implications for negative affective states and psychiatric disorders - ScienceDirect
Molecules | Free Full-Text | Design of κ-Opioid Receptor Agonists for the Development of Potential Treatments of Pain with Reduced Side Effects